Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients - PubMed (original) (raw)
. 2000 Jul 14;11(10):2079-82.
doi: 10.1097/00001756-200007140-00004.
R Krüger, W Kuhn, T Müller, D Woitalla, D Berg, G Becker, E Leroy, M Polymeropoulos, K Berger, H Przuntek, L Schöls, J T Epplen, O Riess
Affiliations
- PMID: 10923647
- DOI: 10.1097/00001756-200007140-00004
Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients
P Wintermeyer et al. Neuroreport. 2000.
Abstract
Recently, an Ile93Met substitution has been identified in the ubiquitin carboxy-terminal hydrolase L1 (UCHL1) gene in a single German PD family with autosomal dominant inheritance. To determine whether mutations in the UCHL1 gene are causative for Parkinson's disease (PD) a detailed mutation analysis was performed in a large sample of German sporadic and familial PD patients. We found no disease-causing mutation in the coding region of the UCHL1 gene. Direct sequencing revealed six intronic polymorphisms in the UCHL1 gene. Analysis of an S18Y polymorphism in exon 3 of the UCHL1 gene in sporadic PD patients and controls showed carriers of allele 2 (tyrosine) significantly less frequent in patients with a reduced risk of 0.57 (CI = 0.36-0.88; p = 0.012, p(c) = 0.047, chi2 = 6.31). Our study shows that sequence variations in the coding region of UCHL1 are a rare event. A protective effect of a certain UCHL1 variant in the pathogenesis of sporadic PD is suggested, underlining the relevance of UCHL1 in neurodegeneration.
Similar articles
- The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease.
Mellick GD, Silburn PA. Mellick GD, et al. Neurosci Lett. 2000 Oct 27;293(2):127-30. doi: 10.1016/s0304-3940(00)01510-x. Neurosci Lett. 2000. PMID: 11027850 - No genetic association of the ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism with familial Parkinson's disease.
Levecque C, Destée A, Mouroux V, Becquet E, Defebvre L, Amouyel P, Chartier-Harlin MC. Levecque C, et al. J Neural Transm (Vienna). 2001;108(8-9):979-84. doi: 10.1007/s007020170017. J Neural Transm (Vienna). 2001. PMID: 11716150 - The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease.
Harhangi BS, Farrer MJ, Lincoln S, Bonifati V, Meco G, De Michele G, Brice A, Dürr A, Martinez M, Gasser T, Bereznai B, Vaughan JR, Wood NW, Hardy J, Oostra BA, Breteler MM. Harhangi BS, et al. Neurosci Lett. 1999 Jul 23;270(1):1-4. doi: 10.1016/s0304-3940(99)00465-6. Neurosci Lett. 1999. PMID: 10454131 - Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson's disease: the impact of ethnicity and onset age.
Liu Y, Chen YY, Liu H, Yao CJ, Zhu XX, Chen DJ, Yang J, Lu YJ, Cao JY. Liu Y, et al. Neurol Sci. 2015 Feb;36(2):179-88. doi: 10.1007/s10072-014-1987-y. Epub 2014 Nov 6. Neurol Sci. 2015. PMID: 25370916 Review. - Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.
Hattori N, Shimura H, Kubo S, Wang M, Shimizu N, Tanaka K, Mizuno Y. Hattori N, et al. J Neural Transm Suppl. 2000;(60):101-16. doi: 10.1007/978-3-7091-6301-6_6. J Neural Transm Suppl. 2000. PMID: 11205133 Review.
Cited by
- Ubiquitin Carboxyl-Terminal Hydrolase L1 and Its Role in Parkinson's Disease.
Buneeva O, Medvedev A. Buneeva O, et al. Int J Mol Sci. 2024 Jan 21;25(2):1303. doi: 10.3390/ijms25021303. Int J Mol Sci. 2024. PMID: 38279302 Free PMC article. Review. - Rotenone-Induced Model of Parkinson's Disease: Beyond Mitochondrial Complex I Inhibition.
Ibarra-Gutiérrez MT, Serrano-García N, Orozco-Ibarra M. Ibarra-Gutiérrez MT, et al. Mol Neurobiol. 2023 Apr;60(4):1929-1948. doi: 10.1007/s12035-022-03193-8. Epub 2023 Jan 3. Mol Neurobiol. 2023. PMID: 36593435 Review. - Genes in familial parkinsonism and their role in sporadic Parkinson's disease.
Krüger R. Krüger R. J Neurol. 2004 Sep;251 Suppl 6:VI/2-6. doi: 10.1007/s00415-004-1602-x. J Neurol. 2004. PMID: 15675717 Review. - UCHL1 S18Y variant is a risk factor for Parkinson's disease in Japan.
Miyake Y, Tanaka K, Fukushima W, Kiyohara C, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson’s Disease Study Group. Miyake Y, et al. BMC Neurol. 2012 Jul 28;12:62. doi: 10.1186/1471-2377-12-62. BMC Neurol. 2012. PMID: 22839974 Free PMC article. - Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration.
Bilguvar K, Tyagi NK, Ozkara C, Tuysuz B, Bakircioglu M, Choi M, Delil S, Caglayan AO, Baranoski JF, Erturk O, Yalcinkaya C, Karacorlu M, Dincer A, Johnson MH, Mane S, Chandra SS, Louvi A, Boggon TJ, Lifton RP, Horwich AL, Gunel M. Bilguvar K, et al. Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3489-94. doi: 10.1073/pnas.1222732110. Epub 2013 Jan 28. Proc Natl Acad Sci U S A. 2013. PMID: 23359680 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous